DRIVE - Brand-specific influenza vaccine effectiveness in Europe, season 2019/20 (DRIVE 2019/20)First published 05/06/2020 Last updated 03/05/2021 EU PAS number: EUPAS35685StudyFinalised
P95 Epidemiology & PharmacovigilanceBelgiumColombiaNetherlandsSouth AfricaThailandUnited States First published: 07/11/2022Last updated 09/04/2024 InstitutionLaboratory/Research/Testing facilityNon-Pharmaceutical companyENCePP partner
Development of Robust and Innovative Vaccine Effectiveness (DRIVE)BelgiumEuropean UnionFinlandFranceItalyNetherlandsSpainUnited Kingdom First published: 22/05/2019Last updated 08/05/2020 NetworkENCePP partner